Juva Life Commences Industrial Scale Cannabis Cultivation at Stockton Facility
Propagated Cannabis seedlings planted to accelerate first harvest.
VANCOUVER, BC, — (GLOBE NEWSWIRE) February 23, 2021 – Juva Life Inc. (CSE: JUVA, OTCQB: JUVAF, FRANKFURT: 4VV) (“Juva” or the “Company”) a California based life sciences company focused on the research, development and commercialization of Cannabis products is extremely pleased to announce the commencement of commercial cannabis cultivation at its Stockton, California facility.
Subsequent to state licensing approval in January, the Juva cultivation team quickly concluded preparatory efforts for plant delivery this week. After 30 months of development effort, Juva Life has entered a vitally important phase of its business development with this week’s planting program now underway within the dedicated flowering rooms at its 30,000 sq. ft. facility.
In a move to accelerate the first two harvests, VP of Horticulture, Thomas Leschak, and his select team of cultivation experts have commenced planting using propagated cannabis clones provided by a 3rd party. Future clones will be developed from a large collection of proprietary genetic seed stock privately developed over the past decade.
Harvested material will be dried within the facility utilizing specially designed, built, and monitored drying rooms. Upon reaching optimal moisture levels, the material will be moved to the dedicated trim area for processing and grading before moving to final curing. The cultivation team anticipates each room to deliver a full harvest five times per year. The process began this week with the first of five flowering rooms fully planted. Once all five rooms are functional, operational scheduling calls for a harvest every twelve days with an anticipated combined annual output of 6,000 pounds of high-quality cannabis flower.
Juva Life placed significant orders of growing medium, nutrients and fertilizers several months ago to ensure a stockpile was on hand and available for immediate use. Juva has also installed advanced onsite nutrient analysis and PH monitoring systems. Extensive monitoring and adaptive controls have been integrated to track feeding schedules based on temperatures, humidity, soil PH and related nutrient data to ensure environmental stability. Filtered reverse osmosis systems treat condensate from HVAC systems to reduce water consumption, and the entire primary power system is provided by low emission natural gas-powered generators. In keeping with the company’s commitment to quality and efficiency, the power system is projected to reduce annual electrical costs by up to 50% and provides separation from the unreliable California power grid which faced multiple regional outages last year which could have resulted in costly crop failures.
Juva Life’s Stockton facility also includes a delivery, packaging, and distribution center. The growing cannabis delivery fleet offers nearly 400 product SKU’s across San Joaquin County with expansion plans into the surrounding region later this year. The separate distribution center will manage B2B shipments of bulk cannabis and future distribution of Juva branded products.
Company Founder and CEO, Doug Chloupek states, “It has been a long time coming, but I’ve always been confident we’d get here as planned. Needless to say, I’m really pleased to finally have our plants in the ground. We can now count the days to increased revenues through commercial sales, and the ability to help fund our life sciences programs which will ultimately lead to an entire class of new proprietary products. We have entered an especially important part of our value proposition. Today marks the day we move beyond development-stage into commercial enterprise.”
For those new to the Juva story, please visit our website at www.juvalife.com
About Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRA: 4VV)
Juva Life is working to bring the cannabis market face to face with the sector’s next generation investment grade business model. From in-house research, cultivation, manufacturing, retail, and delivery services, Juva employs state of the art tools in discovery, development, and data science to identify new molecular profiles for major unmet medical needs. Our initial focus is on cannabis, where we are deploying our platform to target consumer and pharma applications. Find out more at: https://juvalife.com/.
For further information, please contact:
Juva Life Investor Relations
Tel: +1 833-333-5882 (JUVA)
Email: inquiries@juvalife.com
The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.
Forward-Looking Information
Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forwardlooking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile onwww.sedar.com